A

Aspen Pharmacare Holdings Ltd
OTC:APNHY

Watchlist Manager
Aspen Pharmacare Holdings Ltd
OTC:APNHY
Watchlist
Price: 6.9 USD 4.86% Market Closed
Market Cap: 3.1B USD

Gross Margin
Aspen Pharmacare Holdings Ltd

44.1%
Current
46%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
44.1%
=
Gross Profit
19.1B
/
Revenue
43.4B

Gross Margin Across Competitors

No Stocks Found

Aspen Pharmacare Holdings Ltd
Glance View

Market Cap
3.1B USD
Industry
Pharmaceuticals

In the vibrant world of global pharmaceuticals, Aspen Pharmacare Holdings Ltd. stands out as a beacon of South African innovation and business acumen. Founded in Durban in 1997, Aspen has grown from modest beginnings into a multinational powerhouse. The company’s core strength lies in manufacturing and producing a diversified portfolio of pharmaceutical products, including generic medications, branded pharmaceuticals, and over-the-counter consumer health products. It further engages in anesthetics, nutritional products, and critical care drugs, offering solutions to myriad health challenges across more than 50 countries. This diversification not only ensures a broad market appeal but effectively hedges against the risks inherent in the pharmaceutical sector, such as patent expirations and regulatory hurdles. Aspen’s financial blueprint is designed around strategic partnerships and manufacturing competencies that serve both developed and emerging markets. It generates revenue primarily through its extensive distribution network and its ability to produce cost-effective generics that address high-demand therapeutic areas, such as cardiovascular, diabetes, and cancer treatments. The company’s growth is fuelled by both organic expansion and astute acquisitions, such as the incorporation of select portfolios from global giants like GlaxoSmithKline. Aspen meticulously balances manufacturing efficiency with stringent regulatory compliance, operated through state-of-the-art facilities accredited by international regulatory bodies. By maintaining this commitment to quality and cost-efficiency, Aspen differentiates itself from competitors and consolidates its position as a significant player in the global pharmaceutical landscape.

APNHY Intrinsic Value
Not Available
A
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
44.1%
=
Gross Profit
19.1B
/
Revenue
43.4B
What is the Gross Margin of Aspen Pharmacare Holdings Ltd?

Based on Aspen Pharmacare Holdings Ltd's most recent financial statements, the company has Gross Margin of 44.1%.

Back to Top